Discovery of PF-07054894, a Potent Squaramide-Based CCR6 Antagonist Displaying High CXCR2 Selectivity
- 22 September 2025
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (19) , 20689-20716
Abstract
The G protein-coupled receptor (GPCR) CCR6 mediates the migration of pathogenic immune cells to the site of inflammation in response to the chemokine CCL20. CCR6 is an attractive target for the treatment of chronic autoimmune disease as antagonism of the receptor is expected to block CCL20-mediated immune cell recruitment. High-throughput-screening identified a squaramide-based, allosteric antagonist of CCR6 that potently inhibited CCL20-mediated T cell chemotaxis, but it also inhibited CXCL1-mediated neutrophil chemotaxis through CXCR2 antagonism. Lead optimization achieved differentiation from CXCR2 through identification of a methyl substituent-dependent selectivity switch or “magic methyl for selectivity”. The mechanism for this effect is rooted in different antagonist-induced ligand–receptor behaviors, insurmountable for CCR6 and surmountable for CXCR2. Herein, we report the discovery and preclinical evaluation of the CCR6 antagonist PF-07054894 (18l) which has advanced to clinical trials as a first in class approach targeting the receptor.Keywords
This publication has 58 references indexed in Scilit:
- Development of a NanoBRET Assay Platform to Detect Intracellular Ligands for the Chemokine Receptors CCR6 and CXCR1ChemMedChem, 2024
- Targeting the CCR6/CCL20 Axis in Entheseal and Cutaneous InflammationArthritis & Rheumatology, 2021
- UCSF ChimeraX: Structure visualization for researchers, educators, and developersProtein Science, 2020
- Advances in G protein-coupled receptor high-throughput screeningCurrent Opinion in Biotechnology, 2020
- Role of Chemokines and Chemokine Receptors in Cancer2020
- Structural Basis for Allosteric Ligand Recognition in the Human CC Chemokine Receptor 7Cell, 2019
- Identification of a novel series of potent and selective CCR6 inhibitors as biological probesBioorganic & Medicinal Chemistry Letters, 2018
- Development of a new permeability assay using low‐efflux MDCKII cellsJournal of Pharmaceutical Sciences, 2011
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- A LiCl‐Mediated Br/Mg Exchange Reaction for the Preparation of Functionalized Aryl‐ and Heteroarylmagnesium Compounds from Organic BromidesAngewandte Chemie International Edition, 2004